Clinical Trial Update: Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluated combining CO2 fractional laser with bimatoprost 0.03% for alopecia areata; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Bimatoprost 0.03% (bimatoprost)
• CO2 fractional laser

Snippet

Sponsor: Ahmed Hassan Nouh MD | Conditions: Alopecia Areata | Phase 1, Phase 2 | Status: COMPLETED